Sandro L. Boland
Leuven, VLG 3001, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Discovery and Preclinical Profile of ALG-097558, a Pan-Coronavirus 3CLpro Inhibitor.
Journal: Journal of medicinal chemistry
Published: June 30, 2025
Comparison of capillary dried blood spot and capillary microtubes with venous immunoglobulin G levels for routine diagnostics.
Journal: Clinical biochemistry
Published: March 18, 2025
Ibetazol, a novel inhibitor of importin β1-mediated nuclear import.
Journal: Communications biology
Published: May 08, 2024
A coronavirus assembly inhibitor that targets the viral membrane protein.
Journal: Nature
Published: April 06, 2024
The Substitutions L50F, E166A, and L167F in SARS-CoV-2 3CLpro Are Selected by a Protease Inhibitor In Vitro and Confer Resistance To Nirmatrelvir.
Journal: mBio
Published: January 10, 2023
ALG-097111, a potent and selective SARS-CoV-2 3-chymotrypsin-like cysteine protease inhibitor exhibits in vivo efficacy in a Syrian Hamster model.
Journal: Biochemical and biophysical research communications
Published: February 14, 2021
Dual inhibition of SARS-CoV-2 and human rhinovirus with protease inhibitors in clinical development.
Dual inhibition of SARS-CoV-2 and human rhinovirus with protease inhibitors in clinical development.
Journal: Antiviral research
Published: December 08, 2020
Civilian perception of the role of the military in Nigeria's 2014 Ebola outbreak and health-related responses in the North East region.
Journal: BMJ military health
Published: October 20, 2020
Understanding medical civil-military relationships within the humanitarian-development-peace 'triple nexus': a typology to enable effective discourse.
Journal: BMJ military health
Published: November 21, 2019
An allosteric binding site of the α7 nicotinic acetylcholine receptor revealed in a humanized acetylcholine-binding protein.
Journal: The Journal of biological chemistry
Published: August 31, 2017
Rho kinase inhibitors: a patent review (2014 - 2016).
Journal: Expert opinion on therapeutic patents
Published: January 04, 2017
Treatment of Intestinal Fibrosis in Experimental Inflammatory Bowel Disease by the Pleiotropic Actions of a Local Rho Kinase Inhibitor.
Journal: Gastroenterology
Published: September 09, 2016
Last Updated: 09/26/2026